A systematic review and meta‐analysis of ketamine in pediatric status epilepticus

Abstract

AbstractObjectiveStatus epilepticus (SE) is a common neurological medical emergency in the pediatric population, with 10%–40% of cases progressing to refractory SE (RSE), requiring treatment with anesthetic infusions. We present a systematic review and meta‐analysis of the use of ketamine for the treatment of pediatric SE and its potential advantages over other anesthetic infusions.MethodsThis review follows the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) statement. Electronic databases, including PubMed, Cochrane Library, Ovid, Embase, and Google Scholar, were searched with the keywords “pediatrics,” “status epilepticus,” and “ketamine treatment.” Randomized trials, prospective and retrospective cohort studies, and case reports were considered for inclusion.ResultsEighteen publications met the initial inclusion criteria. The 18 publications comprise 11 case reports, one nonconclusive clinical trial, two case series, and four retrospective cohorts. After excluding the case reports because of reporting bias, only the six case series and cohorts were included in the final analysis. There were 172 patients in the six included studies. The weighted age was 9.93 (SD = 10.29) years. The weighted maximum dose was 7.44 (SD = 9.39) mg/kg/h. SE cessation was attained in 51% (95% confidence interval = 43–59) of cases with the addition of ketamine. The heterogeneity was I2 = 0%, t2 = 0, χ2 (5) = 3.39 (p = .64).SignificancePediatric RSE is difficult to treat, resulting in increased morbidity and mortality. Without strong recommendations and evidence regarding preferred agents, this review provides evidence that ketamine may be considered in managing SE in the pediatric population.